2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
AssigneeGilead Sciences, Inc.
InventorsDaniel Drolet, Larry Gold
Life of this patent
Estimating the term…
Abstract
Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.
Claims13
A non-naturally occurring nucleic acid ligand to calf intestinal phosphatase (CIP) identified according to the method comprising:
- a) preparing a candidate mixture of nucleic acids;
- b) contacting the candidate mixture of nucleic acids with CIP, wherein nucleic acids having an increased affinity to CIP relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;
- c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture;
- and
- d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acids with relatively higher affinity and specificity for binding to CIP, whereby a nucleic acid ligand of CIP may be identified.
A purified and non-naturally occurring RNA ligand to CIP wherein said ligand is selected from the group consisting of SEQ. ID. NO. 1-43 as set forth in FIG. 1.
A purified and isolated non-naturally occurring nucleic acid ligand to calf intestinal phosphatase (CIP).
Dependencies are inferred from the claim text.